FOURIER

A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When AMG 145 is Used in Combination With Statin Therapy in Patients with CAD

Stadium
klaar
Middel
AMG 145
Populatie
ASCVD
Fase
III
First Patient In
15 februari 2013
Last Patient In
15 maart 2015
Last Patient Last Visit
4 november 2016

Studiedirecteur

dr. A.H. Liem

Cardioloog

De pagina is verlopen.